The Lancet Infectious Diseases, documents data that originated in Australia in April 2020, the evidence made suggestions that 86% of people interviewed (3,741 of 4,362) would go about getting vaccinated against COVID-19 if they had a vaccine available to them. Dara from the COCONEL group noted in March 2020, 74% of French citizens would get vaccinated. Within the months of April and July 2020, eagerness to vaccinate in the USA was 58%, 64% in the UK, and 74% in New Zealand. In New Zealand, the driving factor to get vaccinated was to protect family and self, even though the safety of the vaccine was the biggest concern.
In the most recent two surveys from the Australian longitudinal study in June and July 2020, the participants responded on a seven-point Likert scale "If a COVID-19 vaccine becomes available, I will get it" (strongly agree, agree, somewhat agree (yes), neither agree nor disagree (indifferent) and somewhat disagree, disagree, strongly disagree (no). Based on the result from June 2020, 87% (1,195 of 1,371) of the study population responded they would get the COVID 19 vaccine if it was available; in July 2020 the percentage rose to 90% (1,144 of 1,274) based on the sample size.
The findings from the study are crucial because they help to illustrate how enthusiastic participants are to receive a COVID 19 vaccine if one became available. The concerns were reasonable due to the fact that developing a vaccine takes roughly 10-15 years. During the process of creating a vaccine, the methods must be available for the public in order to raise the public's trust safety, and effectiveness, especially for those individuals who are willing to get vaccinated. Communicating with experts in the public about promoting a message and long-term vaccine strategy is imperative. A framework from health economists will help in delivering these strategies.